Back
Guidewire Software Vs. Blueprint Medicines Industry Stock Comparison
Buy
56
GWRE
Guidewire Software
Last Price:
$223.91
Seasonality Move:
5.98%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Buy
56
Guidewire Software (GWRE)
is a Buy
Is Guidewire Software a Buy, Sell or Hold?
-
The current Guidewire Software [GWRE] share price is $223.18. The Score for GWRE is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
GWRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GWRE Stock Price Chart
What is Guidewire Software's stock price today?
-
The Guidewire Software share price today is $223.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GWRE is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
GWRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 59.82 | Buy |
Relative Strength Index (14 RSI): | 42.24 | Sell |
Chaikin Money Flow: | -177001 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (222.36 - 240.5) | Sell |
Bollinger Bands (100): | (188.66 - 233.02) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.34 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.13 - 129.21) | Buy |
Bollinger Bands (100): | (86.05 - 122.97) | Buy |
GWRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 221.51 | Buy |
20-day SMA: | 228.05 | Sell |
50-day SMA: | 228.84 | Sell |
200-day SMA: | 200.62 | Buy |
8-day EMA: | 208.43 | Buy |
20-day EMA: | 148.78 | Buy |
50-day EMA: | 79.48 | Buy |
200-day EMA: | 23.28 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.39 | Buy |
20-day SMA: | 128.78 | Buy |
50-day SMA: | 119.98 | Buy |
200-day SMA: | 100.05 | Buy |
8-day EMA: | 129.3 | Buy |
20-day EMA: | 128.05 | Buy |
50-day EMA: | 120.46 | Buy |
200-day EMA: | 103.98 | Buy |
Guidewire Software Earnings Growth & GWRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.16 per share, an increase this year of $1.12 per share, and an increase next year of $0.40 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
Guidewire Software Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |